Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Achieve Life Sciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 32 | 29 | −3 |
| Shares | 1.78M | 1.92M | +136.6K (+7.7%) |
| Value | $15.2M | $14.9M | −$220.0K (−1.5%) |
New holders (4)
Institutions that held Achieve Life Sciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Long Focus Capital Management, LLC | 60,000 | $467.0K | 0.13% |
| Citadel Advisors LLC | 19,207 | $149.0K | 0.00% |
| Pura Vida Investments, LLC | 16,325 | $127.0K | 0.01% |
| Simplex Trading, LLC | 341 | $2.00K | 0.00% |
Sold out (7)
Institutions that held Achieve Life Sciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 38,491 | $327.0K |
| Two Sigma Investments, LP | 18,532 | $158.0K |
| Advisory Services Network, LLC | 13,000 | $111.0K |
| Dimensional Fund Advisors LP | 10,962 | $93.0K |
| Virtu Financial LLC | 10,039 | $85.0K |
| Godsey & Gibb Associates | 453 | $4.00K |
| Bank of America Corp | 46 | $0 |